SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Visible Genetics Inc.(VGIN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert G. Hanah who wrote (308)7/16/1999 3:14:00 AM
From: Kelton  Read Replies (1) of 337
 
From what I have read, the significance of TruPrep RNA extraction is enough to keep me aboard this roller coaster ride of a stock. A ten-fold increase in obtaining genotypes, over an already efficient assay method tells me this company is definitely worth even more than Warburg's financing. I gather that now it is possible that this technology could someday become available as a test kit that patients themselves could administer.
Who doesn't believe that in another few years this technology could branch into other areas, such as genotyping the 100 or so serotypes of rhinovirus?
Well, this is just rambling speculation on my part. Anyone care to add to or disagree with how great a product VGIN's TruePrep could become?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext